Business
Jan 8 (Reuters) - Merck is in talks to buy cancer drug developer Revolution Medicines, the Financial Times reported on Thursday, citing people familiar with the matter.
Shares of Revolution were up ? [+490 chars]
Leave A Comment
Comments
No comments yet. Be the first to comment!
